Approvals/TGA/MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe

Approved

STANDARD

MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe

Amdipharm Mercury Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 46148ec8f4227fe6
Product Name: MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe
Artg Id: 371880
Artg Name: MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe
Sponsor: Amdipharm Mercury Australia Pty Ltd
Company Detail Path: /organization/amdipharm-mercury-australia-pty-ltd
Artg Date: 2022-08-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01368-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01849-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

46148ec8f4227fe6

Type

Standard